Stockreport

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF Data show how AbCellera is expanding the reach of T-cell engagers with:CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing a [Read more]